<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04804306</url>
  </required_header>
  <id_info>
    <org_study_id>C01238</org_study_id>
    <nct_id>NCT04804306</nct_id>
  </id_info>
  <brief_title>Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC</brief_title>
  <official_title>Post Market Clinical Utility of ESId (MDW Hematology Parameter) for Early Sepsis Detection in the Emergency Department (US Hospitals) - Hackensack University Medical Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beckman Coulter, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beckman Coulter, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate that addition of the Monocyte Width Distribution&#xD;
      (MDW) parameter to current standard of care improves a clinician's ability to recognize&#xD;
      sepsis in the Emergency Department, resulting in earlier decision to administer antibiotics&#xD;
      from time of ED presentation for sepsis patients (simulated primary endpoint), with&#xD;
      concomitant reductions in length of stay and in-hospital mortality for those patients&#xD;
      (secondary endpoints).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to develop a method for identifying sepsis patients from&#xD;
      electronic health records (EHR) based on Sepsis-2 criteria. Sepsis patients will be&#xD;
      identified using a Sepsis Definition which includes meeting SIRS score of â‰¥2 within 12 hours&#xD;
      of ED presentation and any microbial testing ordered within 24 hours of ED presentation. The&#xD;
      patient will be enrolled if it meets the Sepsis Definition and additional EMR data elements&#xD;
      will be extracted to complete case report form. Furthermore, objectives include to confirm&#xD;
      the clinical validity and performance of MDW in a control population of sepsis patients where&#xD;
      MDW is measured but not reported to physicians. This study is an observational study which&#xD;
      will simulate the decision impact of MDW on sepsis identification and patient management.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 31, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Potential reduction of Time to Antibiotics</measure>
    <time_frame>Within 12 hours from presentation to the emergency department</time_frame>
    <description>MDW's ability to reduce time to first antibiotics ordered by physician (decision to treat)-Simulated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Performance</measure>
    <time_frame>Within 12 hours from presentation to the emergency department</time_frame>
    <description>MDW's ability to identify Sepsis vs Non-Sepsis when using a Sepsis electronic medical record definition</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Health &amp; Economic Benefits for Hospital Stay - Simulated</measure>
    <time_frame>Within 12 hours from presentation to the emergency department</time_frame>
    <description>MDW's ability to reduce length of hospital stay</description>
  </other_outcome>
  <other_outcome>
    <measure>Health &amp; Economic Benefits for Intensive Care Unit Stay - Simulated</measure>
    <time_frame>Within 12 hours from presentation to the emergency department</time_frame>
    <description>MDW's ability to reduce length of intensive care unit stay</description>
  </other_outcome>
  <other_outcome>
    <measure>Health &amp; Economic Benefits for Mortality - Simulated</measure>
    <time_frame>Within 12 hours from presentation to the emergency department</time_frame>
    <description>MDW's ability to reduce in-house mortality</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Sepsis</condition>
  <condition>Adult Disease</condition>
  <condition>Emergency Department</condition>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Diagnostic Test: CBC-Diff Monocyte Volume Width Distribution</arm_group_label>
    <description>MDW measurement used to detect sepsis as part of the CBC-Diff ordered by ED Physician as part of the Institution's Standard of Care. Results will not be used to manage patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Diagnostic Test: CBC-DIFF Monocyte Volume Width Distribution (MDW)</intervention_name>
    <description>MDW measurement used to detect sepsis. Results will not be used to manage patients.</description>
    <arm_group_label>Diagnostic Test: CBC-Diff Monocyte Volume Width Distribution</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients presenting to the ED where a CBC-Diff has been ordered by standard of&#xD;
        care&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult (18 to 89 years)&#xD;
&#xD;
          -  All race and ethnicities&#xD;
&#xD;
          -  Presenting to the emergency department with suspicion of infection&#xD;
&#xD;
          -  Whose assessment includes a CBC with differential&#xD;
&#xD;
          -  Meets EMR Sepsis Definition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Transfers from other ED&#xD;
&#xD;
          -  Previously enrolled&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Joseph Parrillo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hackensack Meridian Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Keri Bicking, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hackensack Meridian Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liliana Tejidor, PhD</last_name>
    <phone>305-380-2560</phone>
    <email>lmtejidor@beckman.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diana B Careaga, MT</last_name>
    <phone>305-803-1301</phone>
    <email>diana.careaga@beckman.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Joseph Parrillo, MD</last_name>
      <phone>551-996-2336</phone>
      <email>Joseph.Parrillo@hmhn.org</email>
    </contact>
    <contact_backup>
      <last_name>Keri Bicking, PharmD</last_name>
      <phone>551-996-2348</phone>
      <email>Keri.Bicking@hmhn.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

